News|Articles|November 18, 2025
Understanding Anti-Drug Antibody Assessment: Early Discovery through Clinical Trials
Author(s)Prolytix
Learn the unique considerations for use of ADA assays in early development, pre-clinical and clinical settings, as well as how to generate high-quality methods at each stage to support successful development and regulatory approval of safe and effective biotherapeutic drugs.
Related Content
Trending on Pharmaceutical Technology
1
Renewing Prosaic Generics for Cancer Treatment
2
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
3
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
4
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
5